No Data
JonesTrading Maintains Sagimet Biosciences(SGMT.US) With Buy Rating, Maintains Target Price $42
Buy Recommendation for Sagimet Biosciences: Denifanstat's Unique Profile and Undervaluation Offer Compelling Investment Opportunity
This Vital Farms Analyst Begins Coverage On A Bullish Note; Here Are Top 5 Initiations For Monday
Sagimet Biosciences Analyst Ratings
JonesTrading Initiates Sagimet Biosciences(SGMT.US) With Buy Rating, Announces Target Price $42
Analysts Offer Insights on Healthcare Companies: Sagimet Biosciences, Inc. Class A (SGMT) and Blueprint Medicines (BPMC)
![[undefined]](https://static.moomoo.com/nnq/emoji/static/image/default/default-black.png?imageMogr2/thumbnail/36x36 "undefined"){kind=small}